Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 5Recruiting 4Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 1780Neoplasms 1500Carcinoma, Non-Small-Cell Lung 1045Prostatic Neoplasms 958Colorectal Neoplasms 882Lung Neoplasms 803Pancreatic Neoplasms 573Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 541Stomach Neoplasms 513Ovarian Neoplasms 508Neoplasm Metastasis 499Multiple Myeloma 494Recurrence 412Melanoma 387Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 356Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Endometrial Neoplasms 305Triple Negative Breast Neoplasms 299Glioblastoma 299Rectal Neoplasms 282Sarcoma 266Urinary Bladder Neoplasms 264Hematologic Neoplasms 264Colonic Neoplasms 255

Interventions

ofatumumab 1daratumumab 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Anti-N-Methyl-D-Aspartate Receptor Encephalitis × Clear all
NCT06867991 2025-07-15

RADIA

The First People's Hospital of Changzhou

Phase 3 Recruiting
200 enrolled

Autoimmune Diseases of the Nervous System, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT05017142 2024-12-16

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

University of Bern

Recruiting
500 enrolled
CNS

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Encephalitis, Encephalomyelitis, Acute Disseminated, Multiple Sclerosis, Myelitis, Transverse, Neuromyelitis Optica, Optic Neuritis, Autoimmune Diseases of the Nervous System, Vasculitis, Central Nervous System, Lupus Vasculitis, Central Nervous System, Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT06510283 2024-11-20

Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis

Beijing Tongren Hospital

Phase 2 Recruiting
10 enrolled

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

NCT03274375 2023-07-13

IANMDAR

Assistance Publique - Hôpitaux de Paris

Phase 2 Recruiting
20 enrolled

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡